Skip to main content

Table 1 Primers used in the qPCR analyses

From: Microglial inflammation after chronic spinal cord injury is enhanced by reactive astrocytes via the fibronectin/β1 integrin pathway

Gene

Forward primer

Reverse primer

Gapgh

5′-GACTTCAACAGCAACTCCCACTCT-3′

5′-GGTTTCTTACTCCTTGGAGGCCAT-3′

Gfap

5′-TGTACTAACAGAGCGAGCCTATGC-3′

5′-GGGACTTGCTGCCTTTAACATTGG-3′

Col1α1

5′-TGGTCACGTTCAGTTGGTCAAAGG-3′

5′-AACCCTGGAAACAGACGAACAACC-3′

Gap43

5′-GACAGGATGAGGGTAAAGAAGACC-3′

5′-AGAGAGAGAGGGCTCATAGGTAGG-3′

Tnf

5′-TGTGAAAACGGAGCTGAGCTGTCC-3′

5′-GGTTCAGTGATGTAGCGACAGCCT-3′

Msr1

5′-TGGAACACATGAAGGACATGGAGG-3′

5′-AATTCCCATGTTCCTGGACTGACG-3′

Mrc1

5′-ATGTGTCGTGATCGCAGAATTGTG-3′

5′-GGTGTATAACATATCTCTGGGAGG-3′

Ccl1

5′-TGTTACAGAAAGATGGGCTCCTCC-3′

5′-ACTGAGGGAAACTGCAGTCTCTGG-3′

Ccl8

5′-AGAAGCTGACTGGGCCAGATAAGG-3′

5′-ACTCACTGACCCACTTCTGTGTGG-3′

Ccl17

5′-ATGTGAAGAAGGCCATCAGATTGG-3′

5′-TTCGCCTGTAGTGCATAAGAGTCC-3′

Ccl22

5′-AAACTTCAGACTTCCTTGGCCTCC-3′

5′-GAAATCTGATTCTGAGCCTGCTCC-3′

Ccl24

5′-GCAGAAACGGAGGATTTCAACAGC-3′

5′-CTTCTTAGGCATGCACCATCATGC-3′

Cxcl1

5′-GGGAGGCTGTGTTTGTATGTCTTG-3′

5′-CGAGACCAGGAGAAACAGGGTTAA-3′

Cxcl2

5′-CGGATGGCTTTCATGGAAGGAGTG-3′

5′-GCTAAGCAAGGCACTGTGCCTTAC-3′

Cxcl3

5′-TAACAACTCCTGAGAGTTCATACC-3′

5′-CCTTCAAGTTAAGAATAGGCTTGG-3′

Cxcl9

5′-GGAAGCAGTAAATTCTGCGAGTGG-3′

5′-GCACAAAAACCACCTGCATGCAGF-3′

Cxcl10

5′-GTCCTGAGACAAAAGTAACTGCCG-3′

5′-AACTTAGAACTGACGAGCCTGAGC-3′

Cxcl11

5′-CTGTGAATGAATGGTAGGGATGGC-3′

5′-CTGTGAATGAATGGTAGGGATGGC-3′

Cxcl13

5′-ATACCCAACCCACATCCTTGTTCC-3′

5′-CGCAAACCTCTTGTTAGTACGAGC-3′

Il1b

5′-GGGCTGGACTGTTTCTAATGCCTT-3′

5′-CCATCAGAGGCAAGGAGGAAAACA-3′

Il6

5′-CCACAGTGAGGAATGTCCACAAAC-3′

5′-GCTCTCCTAACAGATAAGCTGGAG-3′

Il10

5′-GCTCCAAGACCAAGGTGTCTACAA-3′

5′-CCGTTAGCTAAGATCCCTGGATCA-3′

Il12b

5′-CAGAGCCAGGGAGCTAATGTATGC-3′

5′-ATTTGCATAATAGGGCCTGGTCCC-3′

Il15

5′-GTCCAAATGTTCATCAACACGTCC-3′

5′-TGATCCAAGTGGCTCATTATCTCC-3′

Il23a

5′-AGAATAAAGTCTCGAGCCCTTGGC-3′

5′-TACAGATAATGGCCAAAGCCTGGG-3′

Tgfb1

5′-GTGACAGCAAAGATAACAAACTCC-3′

5′-GAGCTGAAGCAATAGTTGGTATCC-3′

Arg1

5′-TGTATCCCAGCAGTTCCTTTCTGG-3′

5′-ACCTCTCTGGATACCTTTGCTTCC-3′

Igf1

5′-AACTGTCTGGGCCTAAAAGCAAGC-3′

5′-AACAGAGGAGACTTTGCTGTGAGC-3′

Chil3

5′-ATACACAGTGCAAGTTGCAAGGGC-3′

5′-GCTGGTACAGCAGACAAGACATCC-3′

Pdgfa

5′-AGACAGATGTGAGGTGAGATGAGC-3′

5′-ACGGAGGAGAACAAAGACCGCACG-3′

Pdgfb

5′-TACCTCCACTCTGTGTCTTCTTCC-3′

5′-CATCCCATTACAACCTTGCTCACC-3′

Fcgr3

5′-CTCACAAACAAGATGCCTACTGCC-3′

5′-GGATAACAGCTATGCCATCAACCC-3′

Fcgr2b

5′-GTCACTTCTGTGAGTCCTGAAACC-3′

5′-TATAAGCAGTTCCCACGTTGCTGC-3′

CD86

5′-GAACCATCTCTAGATCCAAGAGCC-3′

5′-TTGGCTGTCTTATCCTTGCACAGC-3′

CD163

5′-AGCTAAATGGAACAAGAGCCCAGG-3′

5′-GACCCTATTGCGAACAAGCAAACC-3′

Fn1

5′-TTTACAGCTTCTCCAAGCATCGCC-3′

5′-TCCCTATTGATCCCAGACCAAACC-3′

Fn1 transcript variant 1

5′-ACGGTTTCCCATTACGCCAT-3′

5′-TCATCCGCTGGCCATTTTCT-3′

Fn1 transcript variant 2

5′-ATGAGAAGCCTGGATCCCCT-3′

5′-GGAAGGGTAACCAGTTGGGG-3′

Fn1 transcript variant 3

5′-ATGAGAAGCCTGGATCCCCT-3′

5′-TGTCCGCCTAAAGCCATGTT-3′

Fn1 transcript variant 4

5′-ACGGTTTCCCATTACGCCAT-3′

5′-TCATCCGCTGGCCATTTTCT-3′

Fn1 transcript variant 5

5′-GACCCTTACACGGTTTCCCA-3′

5′-TCATCCGCTGGCCATTTTCT-3′

Fn1 transcript variant 6

5′-ATGAGAAGCCTGGATCCCCT-3′

5′-GAGAGCTTCCTGTCCTGTCT-3′

Fn1 transcript variant 7

5′-GACCCTTACACGGTTTCCCA-3′

5′-TCATCCGCTGGCCATTTTCT-3′

Lamb2

5′-TCGTTCTCCTCATATGTGCCCTCC-3′

5′-TTGAAAGCTCTTGCTAGCCAGGAG-3′